Tibial nerve stimulation in the management of primary sexual dysfunction in patients with multiple sclerosis: a pilot randomized control trial.
Saved in:
| Title: | Tibial nerve stimulation in the management of primary sexual dysfunction in patients with multiple sclerosis: a pilot randomized control trial. |
|---|---|
| Authors: | Giannopapas, Vasileios (AUTHOR), Smyrni, Vassiliki (AUTHOR), Kitsos, Dimitrios K. (AUTHOR), Chasiotis, Athanasios K. (AUTHOR), Stavrogianni, Konstantina (AUTHOR), Papagiannopoulou, Georgia (AUTHOR), Tsivgoulis, Georgios (AUTHOR), Voumvourakis, Konstantinos (AUTHOR), Giannopoulos, Sotirios (AUTHOR), Bakalidou, Daphne (AUTHOR) |
| Source: | Neurological Sciences. Dec2024, Vol. 45 Issue 12, p5849-5858. 10p. |
| Subjects: | Transcutaneous electrical nerve stimulation, Lust, Patients, Neural stimulation, Sexual dysfunction |
| Abstract: | Introduction: Sexual dysfunction (SD) is a common symptom that affects 40–90% of patients with multiple sclerosis (MS). Previous studies have highlighted the negative impact of sexual dysfunction in the mental health status and overall quality of life in patients with MS. Methods: The aim of this study was to examine the effects of transcutaneous tibial nerve stimulation (TTNS) in the primary SD symptoms in patients with MS. A total of 40 participants were randomized (1:1 ratio) to either TTNS or Sham group and received three 20 min sessions over the course of two months. Pre and post intervention SD was evaluated using the Multiple Sclerosis Intimacy Questionnaire (MISQ-15). Results: Statistically significant improvements in the aspects of primary sexual dysfunction were observed in the TTNS group pre-post intervention (specifically erectile function (for males)/vaginal lubrication (for females) (p <.001), orgasm quality and satisfaction for both male and female patients (p <.001), sexual desire (p <.05) and bladder related symptomatology (p <.005). In the sham group pre-post intervention, the only observed improvement was in the sexual desire aspect (p <.05). Post intervention the groups significantly differed erectile function/vaginal lubrication and orgasm quality and satisfaction (p <.05). Conclusions: Our findings underline the efficacy of TTNS in improving primary SD symptoms as well as bladder problems in both male and female patients with MS. TTNS demonstrated significant improvement in the following domains: erectile function, vaginal lubrication, orgasm quality, satisfaction, bladder-related symptoms, and sexual desire. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Introduction: Sexual dysfunction (SD) is a common symptom that affects 40–90% of patients with multiple sclerosis (MS). Previous studies have highlighted the negative impact of sexual dysfunction in the mental health status and overall quality of life in patients with MS. Methods: The aim of this study was to examine the effects of transcutaneous tibial nerve stimulation (TTNS) in the primary SD symptoms in patients with MS. A total of 40 participants were randomized (1:1 ratio) to either TTNS or Sham group and received three 20 min sessions over the course of two months. Pre and post intervention SD was evaluated using the Multiple Sclerosis Intimacy Questionnaire (MISQ-15). Results: Statistically significant improvements in the aspects of primary sexual dysfunction were observed in the TTNS group pre-post intervention (specifically erectile function (for males)/vaginal lubrication (for females) (p <.001), orgasm quality and satisfaction for both male and female patients (p <.001), sexual desire (p <.05) and bladder related symptomatology (p <.005). In the sham group pre-post intervention, the only observed improvement was in the sexual desire aspect (p <.05). Post intervention the groups significantly differed erectile function/vaginal lubrication and orgasm quality and satisfaction (p <.05). Conclusions: Our findings underline the efficacy of TTNS in improving primary SD symptoms as well as bladder problems in both male and female patients with MS. TTNS demonstrated significant improvement in the following domains: erectile function, vaginal lubrication, orgasm quality, satisfaction, bladder-related symptoms, and sexual desire. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 15901874 |
| DOI: | 10.1007/s10072-024-07687-2 |
